Clinical Trials on Refractory Obesity
Total 13224 results
-
University of California, San FranciscoCompletedClinically Severe Obesity | Obesity Recidivism | Inadequate Initial Weight Loss | Poor Weight Loss | Persistent Obesity | Refractory Obesity | Intractable ObesityUnited States
-
University Hospital, Clermont-FerrandAME2P Laboratory, Clermont Auvergne UniversityCompleted
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With Multilineage Dysplasia | Refractory Anemia With Excess Blasts in Transformation | Refractory Anemia...United States
-
Case Comprehensive Cancer CenterCompletedMyelodysplastic Syndromes | Thrombocytopenia | Chronic Myelomonocytic Leukemia | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With Multilineage Dysplasia | Refractory Anemia With Ringed SideroblastsUnited States
-
Boston Children's HospitalCompletedAML | ALL | Biphenotypic Leukemia | Refractory Anemia | Refractory Cytopenia With Multilineage Dysplasia | Refractory Anemia With Ringed Sideroblasts | Undifferentiated Leukemia | Ref. Cytopenia w Multilineage Dysplasia & Ringed Sideroblasts | Refractory Anemia With Excess Blasts-1 (5-10% Blasts) | Refractory... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With... and other conditionsUnited States
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
First Affiliated Hospital of Zhejiang UniversityUnknownRefractory NeoplasmsChina
-
SCRI Development Innovations, LLCBayerCompletedRefractory MalignancyUnited States
-
Samsung Medical CenterCompletedRefractory CancerKorea, Republic of
-
Scottsdale HealthcareTranslational Genomics Research InstituteCompleted
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in Transformation | Refractory Anemia With Ringed...United States
-
Samsung Medical CenterUnknownRefractory CancerKorea, Republic of
-
Antisoma ResearchCompletedRefractory Tumors
-
The First Affiliated Hospital of Xiamen UniversityRecruitingRefractory Solid TumorChina
-
The First Affiliated Hospital of Xiamen UniversityCompletedRefractory Solid TumorChina
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Dr. Tapas K. Das GuptaCompletedRefractory Solid TumorsUnited States
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Cancer | Refractory CancerUnited States
-
University of ZurichUniversity Hospital Inselspital, Berne; Swiss Paraplegic Centre Nottwil; Cantonal...Completed
-
First Affiliated Hospital of Zhejiang UniversityUnknownRefractory NeoplasmsChina
-
National University Hospital, SingaporeOtsuka Pharmaceutical Co., Ltd.Unknown
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
First Affiliated Hospital of Zhejiang UniversityUnknownRefractory NeoplasmsChina
-
University of Southern CaliforniaTerminated
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
National Health Research Institutes, TaiwanNational Cheng-Kung University HospitalRecruiting
-
Second Affiliated Hospital of Soochow UniversityRecruitingAdvanced Refractory Solid TumorsChina
-
CStone PharmaceuticalsBayerCompletedAdvanced Refractory Solid TumorsAustralia
-
Eli Lilly and CompanyCompletedCancer | Refractory Solid TumorUnited States
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
Madeline FieldsRecruitingDrug Resistant Epilepsy | Refractory Epilepsy | Medically Refractory EpilepsyUnited States
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in TransformationUnited States
-
Ruijin HospitalUTC Therapeutics Inc.RecruitingRefractory Malignant Solid NeoplasmChina
-
Ruijin HospitalRecruitingRefractory Solid TumorsChina
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
SupremeCure Pharma Inc.WithdrawnRefractory Solid Tumor
-
SCRI Development Innovations, LLCBayerCompletedRefractory Solid TumorsUnited States
-
Vertex Pharmaceuticals IncorporatedNational Cancer Institute (NCI)WithdrawnRefractory Solid TumorsUnited States
-
Case Comprehensive Cancer CenterFlorida International University; Community Foundation of BrowardRecruitingRelapsed Cancer | Refractory CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingRefractory Solid TumorsUnited States
-
PharmaEngineCompletedRefractory Solid TumorsTaiwan
-
Samsung Medical CenterCompletedRefractory Solid TumorsKorea, Republic of
-
Samsung Medical CenterWithdrawnRefractory Solid TumorsKorea, Republic of
-
Myrexis Inc.CompletedRefractory Solid TumorsUnited States
-
National Institute of CancerologíaNational Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.CompletedRefractory Solid TumorsMexico
-
Centre Hospitalier Universitaire de NiceCompleted
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada